References
- Krause R, Schwab E, Bachhiesl D, Daxbock F, Wenisch C, Krejs GJ, et al. The role of candida in antibiotic-associated diarrhea. J Infect Dis 2001; 184: 1065–9.
- Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 2000; 13: 122–43.
- Barrett-Bee K, Hayes Y, Wilson RG, Ryley JF. A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J Gen Microbiol 1985; 131: 1217–21.
- Ibrahim AS, Mirbod F, Filler SG, Banno Y, Cole GT, Kitajima Y, et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 1995; 63: 1993–8.
- Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 1982; 20: 7–14.
- Samaranayake LP, Raeside JM, MacFarlane TW. Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 1984; 22: 201–7.
- Ghannoum MA, Filler SG, Ibrahim AS, Fu Y, Edwards Jr JE. Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B. Antimicrob Agents Chemother 1992; 36: 2239–44.
- Leidich SD, Ibrahim AS, Fu Y, Koul A, Jessup C, Vitullo J, et al. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem 1998; 273: 26078–6086.
- Prakobphol A, Leffler H, Hoover CI, Fisher SJ. Palmitoyl carnitine, a lysophospholipase-transacylase inhibitor, prevents Candida adherence in vitro. FEMS Microbiol Lett 1997; 151: 89–94.